DND PharmaTech (347850.KQ) Stock Price

DND PharmaTech Price

CLOSED
38,650.00
​
Market closed

Over the last 4 years DND PharmaTech grew revenue by 33.2% annually, reaching 4.30 B KRW. For DND PharmaTech, the net margin of -548.1% is up versus -5,001.4% a few years ago.

DND PharmaTech stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DND PharmaTech business model & stock analysis

DND PharmaTech Inc, headquartered in Seongnam, Gyeonggi-Do, South Korea, is a clinical-stage biotech company focused on researching and developing medicines for metabolic diseases, neurodegenerative conditions, and fibrotic disorders. The company's pipeline includes therapeutic medicines targeting diabetes, obesity, and nonalcoholic steatohepatitis, with operations primarily based in South Korea. Listed on May 2, 2024, the firm operates within the healthcare sector.

Frequently asked questions about DND PharmaTech

Converted at the current exchange rate, the DND PharmaTech share trades at 25.75 EUR (38,650.00 KRW).

The revenue cannot currently be calculated for DND PharmaTech.

The profit cannot currently be calculated for DND PharmaTech.

The P/E ratio cannot be calculated for DND PharmaTech at the moment.

The P/S cannot be calculated for DND PharmaTech currently.

The Eulerpool Quality Score for DND PharmaTech is 2/10.

The ISIN of DND PharmaTech is KR7347850000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of DND PharmaTech is 347850.KQ. The ticker symbol is used to trade DND PharmaTech shares on the stock exchange.

Fair ValueTerminal
33,625.50 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
May 2, 2024
ISIN
KR7347850000
Cusip
Y2R2Z2103
Market capitalization
1.57 T KRWMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
19.72
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-29.63 %
Last updated Oct 18, 2026, 7:03 PM

DND PharmaTech Peer Group